skip to content
Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use Preview this item
ClosePreview this item
Checking...

Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use

Author: Canadian Agency for Drugs and Technologies in Health,
Publisher: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 21 November 2014.
Series: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Edition/Format:   eBook : Document : English
Summary:
Surgical site infections (SSIs) account for approximately 20% of all compromised wounds in the Canadian healthcare setting. It is estimated that 6.3% of surgical wounds in Canada result in infection. An overall SSI rate of 2.5% was reported in a sample of hospitalized adults across Canada. In addition to increasing the risk of morbidity, delayed recovery, and prolonged hospital stay, SSIs may increase Canadian  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health,
OCLC Number: 905297877
Notes: Title from PDF caption title.
"CADTH Rapid Response Service."
Description: 1 online resource (1 PDF file (26 pages)) : illustrations.
Series Title: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Responsibility: prepared by Canadian Agency for Drugs and Technologies in Health.

Abstract:

Surgical site infections (SSIs) account for approximately 20% of all compromised wounds in the Canadian healthcare setting. It is estimated that 6.3% of surgical wounds in Canada result in infection. An overall SSI rate of 2.5% was reported in a sample of hospitalized adults across Canada. In addition to increasing the risk of morbidity, delayed recovery, and prolonged hospital stay, SSIs may increase Canadian healthcare costs associated with surgical procedures. It is estimated that the incidence of SSIs could be reduced by over 50% with the implementation of various evidence-based prevention strategies. Risk factors for SSIs include patient related factors (e.g., diabetes, obesity), category of wound (e.g., clean, clean-contaminated), bacterial species, and hospital-related infection prevention measures. Sutures may act as a medium for bacterial growth and it has been demonstrated by in-vitro and in-vivo animal studies that antimicrobial coating may reduce the risk of SSIs. Antimicrobial sutures, which are currently commercially limited to triclosan coated sutures (TCS) (e.g., Vicryl [polyglactin 910] Plus, Monocryl [poliglecaprone 25] Plus, PDS [polydioxanone] Plus), are targeted for the prevention of SSIs. Although antimicrobial sutures are more costly than conventional sutures, if effective for SSI prevention they may reduce surgery related costs. The reported clinical efficacy of antimicrobial sutures is inconsistent, with some systematic reviews reporting an overall benefit, while others do not. A previous CADTH report summarized evidence suggesting that TCS reduced SSIs compared to non-coated sutures.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/905297877> # Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
    a schema:Book, schema:MediaObject, schema:CreativeWork ;
    library:oclcnum "905297877" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/sutures_microbiology> ; # Sutures--microbiology
    schema:about <http://dewey.info/class/617.9178/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/comparative_effectiveness_research> ; # Comparative Effectiveness Research
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/anti_bacterial_agents_therapeutic_use> ; # Anti-Bacterial Agents--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/triclosan_therapeutic_use> ; # Triclosan--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/surgical_wound_infection_prevention_&_control> ; # Surgical Wound Infection--prevention & control
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Place/canada> ; # Canada.
    schema:about <http://experiment.worldcat.org/entity/work/data/2474501407#Topic/guidelines_as_topic> ; # Guidelines as Topic
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/2474501407#Organization/canadian_agency_for_drugs_and_technologies_in_health> ; # Canadian Agency for Drugs and Technologies in Health,
    schema:datePublished "2014" ;
    schema:description "Surgical site infections (SSIs) account for approximately 20% of all compromised wounds in the Canadian healthcare setting. It is estimated that 6.3% of surgical wounds in Canada result in infection. An overall SSI rate of 2.5% was reported in a sample of hospitalized adults across Canada. In addition to increasing the risk of morbidity, delayed recovery, and prolonged hospital stay, SSIs may increase Canadian healthcare costs associated with surgical procedures. It is estimated that the incidence of SSIs could be reduced by over 50% with the implementation of various evidence-based prevention strategies. Risk factors for SSIs include patient related factors (e.g., diabetes, obesity), category of wound (e.g., clean, clean-contaminated), bacterial species, and hospital-related infection prevention measures. Sutures may act as a medium for bacterial growth and it has been demonstrated by in-vitro and in-vivo animal studies that antimicrobial coating may reduce the risk of SSIs. Antimicrobial sutures, which are currently commercially limited to triclosan coated sutures (TCS) (e.g., Vicryl [polyglactin 910] Plus, Monocryl [poliglecaprone 25] Plus, PDS [polydioxanone] Plus), are targeted for the prevention of SSIs. Although antimicrobial sutures are more costly than conventional sutures, if effective for SSI prevention they may reduce surgery related costs. The reported clinical efficacy of antimicrobial sutures is inconsistent, with some systematic reviews reporting an overall benefit, while others do not. A previous CADTH report summarized evidence suggesting that TCS reduced SSIs compared to non-coated sutures."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/2474501407> ;
    schema:genre "Review"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/2474501407#Series/rapid_response_report_canadian_agency_for_drugs_and_technologies_in_health> ; # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/2474501407#Series/rapid_response_report_summary_with_critical_appraisal> ; # Rapid response report: summary with critical appraisal
    schema:name "Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use"@en ;
    schema:productID "905297877" ;
    schema:url <http://www.deslibris.ca/ID/245173> ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK263224> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3296302> ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK263224/> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/905297877> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2474501407#Organization/canadian_agency_for_drugs_and_technologies_in_health> # Canadian Agency for Drugs and Technologies in Health,
    a schema:Organization ;
    schema:name "Canadian Agency for Drugs and Technologies in Health," ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Series/rapid_response_report_canadian_agency_for_drugs_and_technologies_in_health> # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/905297877> ; # Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
    schema:name "Rapid response report (Canadian Agency for Drugs and Technologies in Health)" ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Series/rapid_response_report_summary_with_critical_appraisal> # Rapid response report: summary with critical appraisal
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/905297877> ; # Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
    schema:name "Rapid response report: summary with critical appraisal" ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/anti_bacterial_agents_therapeutic_use> # Anti-Bacterial Agents--therapeutic use
    a schema:Intangible ;
    schema:name "Anti-Bacterial Agents--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/comparative_effectiveness_research> # Comparative Effectiveness Research
    a schema:Intangible ;
    schema:name "Comparative Effectiveness Research"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/guidelines_as_topic> # Guidelines as Topic
    a schema:Intangible ;
    schema:name "Guidelines as Topic"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/surgical_wound_infection_prevention_&_control> # Surgical Wound Infection--prevention & control
    a schema:Intangible ;
    schema:name "Surgical Wound Infection--prevention & control"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/sutures_microbiology> # Sutures--microbiology
    a schema:Intangible ;
    schema:name "Sutures--microbiology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2474501407#Topic/triclosan_therapeutic_use> # Triclosan--therapeutic use
    a schema:Intangible ;
    schema:name "Triclosan--therapeutic use"@en ;
    .

<http://www.worldcat.org/title/-/oclc/905297877>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/905297877> ; # Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
    schema:dateModified "2018-01-08" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.